Week Ahead: U.S Cannabis Earnings Expectations For CRON, CURA, IIPR And More
Cannabis investors are facing a harsh 2023 as shares of the largest U.S cannabis companies are off between 70% and
Read moreCannabis investors are facing a harsh 2023 as shares of the largest U.S cannabis companies are off between 70% and
Read moreCronos Group (TSX: CRON) this morning continued to demonstrate how not to run a cannabis operation. The firm released its
Read moreA Capital Markets Tribunal panel yesterday accepted a settlement agreement between the Ontario Securities Commission and Cronos Group Inc (TSX:
Read moreCanadian cannabis company Cronos Group Inc (TSX: CRON) and its former senior executive were charged with accounting fraud for improperly
Read moreYesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian cannabis companies, being Cronos Group
Read moreOn May 10, Cronos Group (TSX: CRON) reported its first quarter financial results. The company announced that its revenues doubled
Read moreCronos Group (TSX: CRON) this morning posted its first quarter financial results for 2022. Surprisingly, the company appears to be
Read moreAfter less than two years on the job, Kurt Schmidt has retired as the chief executive officer of Cronos Group
Read moreYesterday, Cronos Group (TSX: CRON) reported their fourth-quarter and full-year financial results. The company reported revenues of $25.8 million for
Read moreCronos Group (TSX: CRON) appears to be finally taking steps to address its absolute lack of ability to generate any
Read more